SEE CORRESPONDING ARTICLE ON PAGE 28
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Biological PsychiatryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Prospective validation that subgenual connectivity predicts antidepressant efficacy of transcranial magnetic stimulation sites.Biol Psychiatry. 2018; 84: 28-37
- Functional connectivity of the subcallosal cingulate cortex and differential outcomes to treatment with cognitive-behavioral therapy or antidepressant medication for major depressive disorder.Am J Psychiatry. 2017; 174: 533-545
- Resting-state connectivity biomarkers define neurophysiological subtypes of depression.Nat Med. 2017; 23: 28-38
- Brain disorders? Precisely.Science. 2015; 348: 499-500
- Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: A sham-controlled randomized trial.Arch Gen Psychiatry. 2010; 67: 507-516
- Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate.Biol Psychiatry. 2012; 72: 595-603
- NIMH only accepts clinical trial applications proposing mechanistic studies for clinical trial parent R01 and R21 announcements.(Available at:) (Accessed April 2, 2018)
- Support for clinical trials at NIMH.(Available at:)https://www.nimh.nih.gov/funding/opportunities-announcements/clinical-trials-foas/index.shtml(Accessed April 2, 2018)Date: 2018
- NIMH non-invasive brain stimulation e-field modeling workshop.(Available at:) (Accessed April 2, 2018)
- FDA regulation of neurological and physical medicine devices: Access to safe and effective neurotechnologies for all Americans.Neuron. 2016; 92: 943-948
Article info
Publication history
Accepted:
April 17,
2018
Received:
April 10,
2018
Identification
Copyright
Published by Elsevier Inc on behalf of Society of Biological Psychiatry.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Prospective Validation That Subgenual Connectivity Predicts Antidepressant Efficacy of Transcranial Magnetic Stimulation SitesBiological PsychiatryVol. 84Issue 1
- PreviewThe optimal target in the dorsolateral prefrontal cortex for treating depression with repetitive transcranial magnetic stimulation (rTMS) remains unknown. Better efficacy has been associated with stimulation sites that are 1) more anterior and lateral and 2) more functionally connected to the subgenual cingulate. Here we prospectively test whether these factors predict response in individual patients.
- Full-Text
- Preview
